Stockscreener 앱 받기
9.53
1.24%
-0.12
시간 외 거래:
9.54
0.010
+0.10%
Evolus Inc 주식(EOLS)의 최신 뉴스
Should I buy Evolus Inc. stock before earningsUnmatched market gains - jammulinksnews.com
What drives Evolus Inc. stock priceSignificant capital appreciation - PrintWeekIndia
Is Evolus Inc. a good long term investmentRobust investment performance - jammulinksnews.com
What analysts say about Evolus Inc. stockSky-high profits - Autocar Professional
Evolus to Report Second Quarter Financial Results on August 5, 2025 - BioSpace
Evolus Inc. Stock Analysis and ForecastDynamic investment opportunities - jammulinksnews.com
EvolusA Slightly Risky Buy Ahead Of Q2 Earnings (NASDAQ:EOLS) - Seeking Alpha
Midday Stock Roundup: loanDepot Up 10% with High Volume - Orange County Business Journal
How Evolus Inc. stock performs during market volatilityInsider Level Guidance - Newser
What makes Evolus Inc. stock price move sharplyTop Analyst Picks - Newser
Why Evolus Inc. stock attracts strong analyst attentionRisk Controlled Trading Ideas - Newser
Evolus announces inducement grants - Medical Buyer
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 11, 2025 - BioSpace
How reliable are EOLS's earnings forecasts historically? - AInvest
Is EOLS's Q1 2025 earnings forecast optimistic? - AInvest
Evolus Expands into French Market - Orange County Business Journal
EOLS Partners with Symatese for Nuceiva Distribution in France | - GuruFocus
Fastest-Growing Botox Alternative Nuceiva Enters French Beauty Market Through Strategic Partnership - Stock Titan
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France - Yahoo Finance
Trade Alert: President Of Evolus David Moatazedi Has Sold Stock - simplywall.st
Where are the Opportunities in (EOLS) - news.stocktradersdaily.com
2.82%
0.27%
자본화:
|
볼륨(24시간):